首页> 外文期刊>Therapeutics and Clinical Risk Management >The risk reduction of recurrent periodontal pathogens of local application minocycline HCl 2% gel, used as an adjunct to scaling and root planing for chronic periodontitis treatment
【24h】

The risk reduction of recurrent periodontal pathogens of local application minocycline HCl 2% gel, used as an adjunct to scaling and root planing for chronic periodontitis treatment

机译:降低局部应用美诺环素HCl 2%凝胶的复发性牙周病原体的风险,可作为慢性牙周炎治疗的结垢和根部平整的辅助手段

获取原文
           

摘要

Background: The aim of this study was to evaluate the clinical and microbiological effects of local application minocycline HCl 2% gel, used as an adjunct to scaling and root planing (SRP) for treatment of chronic periodontitis (CP). CP is an inflammation of periodontal tissue that is caused mainly by bacterial infection, where periodontal destruction such as loss of attachment and bone destruction occurred. Methods: A total of 81 subjects with moderate to severe periodontitis whose baseline clinical attachment loss (CAL) was ≥4 mm were randomly assigned to receive SRP alone (control group, N=39) or SRP followed by four times of local application of minocycline HCl gel (Periocline) once a week (test group, N=42). Pocket depth, CAL, and papilla bleeding index were examined at baseline, 21 days, 2, 3, and 6 months. Subgingival plaque samples were collected with sterile curettes and were analyzed by real-time polymerase chain reaction for the presence of three periodontal pathogens ( Porphyromonas gingivalis [P.g.], Tannerella forsythia [T.f.], and Treponema denticola [T.d.]) at baseline, 2, 3, and 6 months. Results: The number of bacteria was reduced in both groups at 2 months after baseline (SRP treatment). The changes (2–6 months) in T.d. and T.f. counts in the test group were significantly lower than those in the control group. In the control group, a significant regrowth of P.g., T.f., and T.d. was observed from 2 to 6 months and of P.g. and T.f. from 3 to 6 months. On the other hand, in the test group, the number of the three bacteria did not significantly increase during the 6-month period. Conclusion: The results showed that local application of minocycline, used as an adjunct to SRP, was effective for suppressing regrowth of periodontal pathogens, suggesting its risk reduction of recurrent periodontal pathogens in CP.
机译:背景:这项研究的目的是评估局部应用美诺环素HCl 2%凝胶的临床和微生物学效果,该凝胶可作为结垢和根部平整(SRP)的辅助治疗慢性牙周炎(CP)。 CP是牙周组织的炎症,主要由细菌感染引起,其中发生牙周破坏,例如附着力丧失和骨破坏。方法:将81例基线至临床附着丧失(CAL)≥4mm的中度至重度牙周炎患者随机分配为单独接受SRP(对照组,N = 39)或SRP,然后四次局部应用米诺环素每周一次使用HCl凝胶(Periocline)(测试组,N = 42)。在基线,21天,2、3和6个月时检查囊袋深度,CAL和乳头出血指数。用无菌刮匙收集龈下菌斑样品,并通过实时聚合酶链反应分析基线时的三种牙周病原体(牙龈卟啉单胞菌[Pg],连翘坦氏菌[Tf]和密螺旋体梅毒螺旋体[Td])的存在,2, 3和6个月。结果:基线(SRP治疗)后两个月,两组细菌数量均减少。 T.d.的变化(2-6个月)。和T.f.测试组的计数显着低于对照组。在对照组中,P.g.,T.f。和T.d.显着再生。在2至6个月内观察到P.g.和T.f. 3至6个月。另一方面,在测试组中,三种细菌的数量在6个月内没有明显增加。结论:结果表明,局部应用美诺环素作为SRP的辅助剂,可有效抑制牙周病原体的再生,表明其降低了CP中牙周病原体复发的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号